pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,546 catalysts · 3,603 8k filing · 2,280 grant · 1,746 approval · 1,120 device 510k · 1,000 device adverse event · 821 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×type: grant×from 2025-12-08×clear all
type
  • 8k filing3,603
  • grant2,280
  • approval1,746
  • device 510k1,120
  • device adverse event1,000
  • device pma821
device recall
602
  • earnings585
  • recall266
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Dec 8, 2025

    21
    ›Dec 10, 2025recall262d agoGlenmark Pharmaceuticals Inc., USA recall (Cls III)LB PHARMACEUTICALS INC

    Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430. — Reason: Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoSafecor Health, LLC recall (Cls II)Mylan Institutional Inc

    Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health LLC KITCHECK RFID Tag attached with incorrect serial numbers: KITCHECK 8001-03A3,00000000,003A-2560, and 8001-03A3,00000000,003A-2D3B. — Reason: Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoPark Avenue Compounding recall (Cls II)Sawai Man Singh Medical College

    Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10. — Reason: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA, Made in India, NDC 67777-407-04. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation, MIddletown, NY 10941 USA, Made in India, NDC 67777-402-01. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10. — Reason: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoTeva Pharmaceuticals USA, Inc recall (Cls III)Terns Pharmaceuticals, Inc.

    Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17. — Reason: Defective Container - A defect in the side-seal which allows leakage of product. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoCipla Limited recall (Cls II)Cipla Ltd

    Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96 — Reason: Failed Stability Specifications: Observed OOS results: eg results for colour index — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 10, 2025recall262d agoBlossom Pharmaceuticals recall (Cls II)OB Pharmaceuticals

    WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05. — Reason: cGMP deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 12, 2025grant260d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Resilience, cultural alignment, and social support in brain aging: Data from ...

    AG grant. $629,111. PI: Astrid M Suchy-Dicey

    full page →nih reporter ↗

    Week of Dec 15, 2025

    29
    ›Dec 15, 2025grant257d agoJACKSON LABORATORY — Genetic dissection of microglia functions in complement-mediated synapse loss...

    AG grant. $716,579. PI: Erik Bradley Bloss

    full page →nih reporter ↗
    ›Dec 15, 2025grant
    ← prev
    page 1 of 51
    next →
    257d ago
    UNIVERSITY OF VIRGINIA — Model-Based Syllabic Prediction in the Avian Auditory PalliumUniversity of Virginia

    DC grant. $41,394. PI: Bao Le

    full page →nih reporter ↗
    ›Dec 15, 2025grant257d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — The Role of APP-metabolites on Extracellular Vesicle Cargo and Function

    AG grant. $639,838. PI: MARC D TAMBINI

    full page →nih reporter ↗
    ›Dec 15, 2025grant257d agoCLEVELAND CLINIC LERNER COM-CWRU — Endothelial TLR2/4 signaling in sex dimorphism of pathological angiogenesis a...

    AG grant. $659,309. PI: Tatiana V Byzova

    full page →nih reporter ↗
    ›Dec 15, 2025grant257d agoUNIVERSITY OF MISSOURI-COLUMBIA — Targeting LARP6 in aging-associated heart failure

    AG grant. $429,394. PI: Shawn Brady Bender

    full page →nih reporter ↗
    ›Dec 16, 2025grant256d agoUNIVERSITY OF WASHINGTON — Landscape Immunity, Climate, and Yellow Fever RiskUniversity of Washington

    AI grant. $47,459. PI: Hilary McLeland-Wieser

    full page →nih reporter ↗
    ›Dec 17, 2025recall255d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98. — Reason: Failed stability specifications: Out of specification for hardness test — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoDr. Reddy's Laboratories, Inc. recall (Cls III)DR REDDYS LABORATORIES LTD

    Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56 — Reason: Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoWinder Laboratories, LLC recall (Cls III)Winder Laboratories LLC

    Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01 — Reason: Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoLupin Pharmaceuticals Inc. recall (Cls II)LB PHARMACEUTICALS INC

    Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01 — Reason: Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoLupin Pharmaceuticals Inc. recall (Cls II)LB PHARMACEUTICALS INC

    Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09. — Reason: Defective container - seal not adhering to bottles — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02 — Reason: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02 — Reason: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13. — Reason: Failed stability specifications: Out of specification for hardness test — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02 — Reason: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoGlenmark Pharmaceuticals Inc., USA recall (Cls III)LB PHARMACEUTICALS INC

    Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90. — Reason: Cross Contamination with Other Products — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025recall255d agoFagron Compounding Services recall (Cls II)Sawai Man Singh Medical College

    Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01 — Reason: Incorrect Product Formulation — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 17, 2025grant255d agoCREIGHTON UNIVERSITY — Peripheral auditory signaling regulates the cochlear efferent system

    GM grant. $291,000. PI: Hui Hong

    full page →nih reporter ↗
    ›Dec 18, 2025grant254d agoSTATE UNIVERSITY OF NEW YORK AT BUFFALO — Investigating the role of peripheral nerve damage in chronic Toxoplasma infec...

    AI grant. $35,157. PI: Caleb Buerger

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Plasticity and social neuromodulation of developing auditory cortical circuitsNew York University

    DC grant. $134,109. PI: Megan Anne Kirchgessner

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoUNIVERSITY OF MINNESOTA — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)University of Minnesota

    HL grant. $794,063. PI: JAMES S PANKOW

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Examining the role of locus coeruleus glucagon-like peptide-1 receptors infee...Xeris Biopharma Holdings, Inc.

    DK grant. $150,930. PI: Samantha Fortin

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoUNIVERSITY OF WASHINGTON — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - TASK AREA AUniversity of Washington

    HL grant. $3,202,749. PI: Robyn Leagh McClelland

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoUNIVERSITY OF CALIFORNIA BERKELEY — Leveraging Adaptive Evolution and High-Throughput Techniques to Dissect the L...

    OD grant. $802,500. PI: Margaux Pinney

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoNORTHWESTERN UNIVERSITY AT CHICAGO — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTERNorthwestern University

    HL grant. $829,413. PI: NORRINA Bai ALLEN

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoJOHNS HOPKINS UNIVERSITY — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)Johns Hopkins University

    HL grant. $697,200. PI: WENDY S POST

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC), TASK AREA AUniversity of California Los Angeles

    HL grant. $674,872. PI: KAROL E WATSON

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoWAKE FOREST UNIVERSITY HEALTH SCIENCES — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER, TASK AREA AWake Forest University

    HL grant. $505,956. PI: Alain Gerald Bertoni

    full page →nih reporter ↗
    ›Dec 19, 2025grant253d agoGEORGE WASHINGTON UNIVERSITY — AIDS and Cancer Specimen Resource (ACSR)

    CA grant. $897,500. PI: Jeffrey Michael Bethony

    full page →nih reporter ↗
    $LBRX47.73-0.33%
    $TERN52.95-0.03%
    $LBRX47.73-0.33%
    $RDY12.19-0.29%
    $LBRX47.73-0.33%
    $LBRX47.73-0.33%
    $XERS8.6000-0.92%